, Volume 11, Issue 6, pp 541–548 | Cite as

Radioimmunological determination of human C-peptide in serum

  • L. G. Heding


A routine radioimmunoassay for human C-peptide in serum is described. Antibodies against human C-peptide were raised by immunizing guinea pigs with human b-component. Nine out of 12 animals produced useful antibodies within 6 months. Insulin antibodies coupled to Sepharose were used to bind human proinsulin and insulin in the serum and after centrifugation C-peptide was determined in the supernatant. The detection limit of the assay (calculated as 2 SD from zero) was about 0.003 pmole of C-peptide (in 100 μl). The main sources of error were: (1) Normal and diabetic sera devoid of C-peptide gave a displacement of125I-Tyr-C-peptide varying from 0 to 0.16 nM (6 different antisera). Only one antiserum (M 1181) showed no displacement, and the values of C-peptide determined with this antiserum in normal and diabetic sera were lower than the values determined with another antiserum, which gave a value of 0.07 nM in the sera free of C-peptide. It is suggested that displacement found with most antisera is due to substances in serum that are not related to C-peptide or proinsulin. (2) Serial dilutions of pancreatic extracts and sera may yield dilution curves slightly different to those of the synthetic standard. Possible explanations are discussed. These sources of error can be eliminated or reduced by the proper selection of antisera. Fasting sera from 15 normals, 8 maturity-onset diabetics and 10 insulin-requiring diabetics showed the following concentrations of C-peptide: (M 1181) 0.35±0.09, 0.74+0.51 and 0.21±0.14 (nM, mean±SD). One hour after 1.75 g/kg oral glucose the values increased to 2.24±0.71, 2.34±1.18 and 0.42 ± 0.24 nM.

Key words

Radioimmunoassay human C-peptide human pro-insulin insulin 


  1. 1.
    Block, M.B., Mako, M., Steiner, D.F., Rubenstein, A.H.: Elevated circulating proinsulin levels in insulin-requiring diabetic patients. J. Lab. clin. Med.78, 811–812 (1971)Google Scholar
  2. 2.
    Block, M.B., Mako, M.E., Steiner, D.F., Rubenstein, A.H.: Circulating C-peptide immunoreactivity. Studies in normals and diabetic patients. Diabetes21, 1013–1026 (1972)Google Scholar
  3. 3.
    Fink, G., Cresto, J.C., Gutman, R.A., Lavine, R.L., Rubenstein, A.H., Recant, L.: Plasma proinsulin-like material in insulin treated diabetics. Horm. Metab. Res.6, 439–443 (1974)Google Scholar
  4. 4.
    Heding, L.G.: Determination of total serum insulin (IRI) in insulin treated diabetic patients. Diabetologia8, 260–266 (1972)Google Scholar
  5. 5.
    Heding, L.G.: Radioimmunological determination of pancreatic and gut glucagon in plasma. Diabetologia7, 10–19 (1972)Google Scholar
  6. 6.
    Heding, L.G., Larsen, U.D., Markussen, J., Jorgensen, K.H. Hallund, O.: Radioimmunoassays for human, pork and ox C-peptides and related substances. Horm. Metab. Res. Suppl. Vol.5, 40–44 (1974)Google Scholar
  7. 7.
    Heding, L.G., Turner, R.C., Harris, E.: C-peptide, proinsulin and insulin responses to fish-insulin induced hypoglycaemia in the diagnosis of insulinomas. Diabetes24 (Suppl. 2), 412 (1975)Google Scholar
  8. 8.
    Kaneko, T., Oka, H., Munemura, M., Oda, T., Yamashita, K., Suzuki, S., Yanaihara, N., Hashimoto, T., Yanaihara, C.: Radioimmunoassay of human proinsulin C-peptide using synthetic human connecting peptide. Endocr. jap.21, 141–145 (1974)Google Scholar
  9. 9.
    Markussen, J., Sundby, F., Smyth, D.G., Ko, A.: Preparation of human C-peptide. Horm. Metab. Res.3, 229–232 (1971)Google Scholar
  10. 10.
    Markussen, J., Heding, L.G., Jørgensen, K.H., Sundby, F.: Proinsulin, insulin and C-peptide. Horm. Metab. Res. Suppl. Series No.3, 33–35 (1971)Google Scholar
  11. 11.
    Naithani, V.K., Dechesne, M., Markussen, J., Heding, L.G., Larsen, U.D.: Studies on Polypeptides, VI1, synthesis, circular dichroism and immunological studies of tyrosyl human C-peptide. Hoppe-Seylers Z. physiol. Chem.356, 1305–1312 (1975)Google Scholar
  12. 12.
    Naithani, V.K., Dechesne, M., Markussen, J., Heding L.G.: Studies on polypeptides, V1. Improved synthesis of human proinsulin C-peptide and its benzyloxy-carbonyl derivative. Circular dichroism and immunological studies of human C-peptide. Hoppe-Seylers Z. physiol. Chem.356, 997–1010 (1975)Google Scholar
  13. 13.
    Östman, J., Arner, P., Groth, C.-G., Heding, L., Jorfeldt, L., Lundgren, G.: Pancreastransplantation vid diabetes mellitus: Studier av pankreas endokrina funktion och intermedicinska synspunkter. (paper in preparation)Google Scholar
  14. 14.
    Rubenstein, A.H., Block, M.B., Starr, J., Melani, F., Steiner, D.F.: Proinsulin and C-peptide in blood. Diabetes21 (Suppl. 2), 661–672 (1972)Google Scholar
  15. 15.
    Turner, R.C., Harris, E.: Diagnosis of insulinomas by suppression tests. Lancet1974 II, 188–190Google Scholar
  16. 16.
    Schlichtkrull, J.: Proinsuline et substances apparantées. Path. et Biol.19, 885–892 (1971)Google Scholar
  17. 17.
    Yanaihara, N., Hashimoto, T., Yanaihara, C., Sakagami, M., Steiner, D.F., Rubenstein, A.H.: Synthesis of human connecting peptide derivatives and their immunological properties. Biochem. biophys. Res. Commun.59, 1124–1130 (1974)Google Scholar

Copyright information

© Springer-Verlag 1975

Authors and Affiliations

  • L. G. Heding
    • 1
  1. 1.Novo Research InstituteCopenhagenDenmark

Personalised recommendations